Eight Years of Clinical Improvement in MPTP-Lesioned Primates After Gene Therapy With AAV2-hAADC

Hadaczek, Piotr, Eberling, Jamie L, Pivirotto, Philip, Bringas, John, Forsayeth, John, Bankiewicz, Krystof S·2010·Molecular Therapy
DOI 10.1038/mt.2010.106

Cited by (156)

Items 101–156 of 156

  1. Gene therapy for Parkinson’s disease: state-of-the-art treatments for neurodegenerative disease
    Michael R. Douglas · 2013 · Expert Review of Neurotherapeutics
  2. Slow AAV2 clearance from the brain of nonhuman primates and anti-capsid immune response
    Lluı́s Samaranch, Piotr Hadaczek, Adrian P. Kells, John R. Bringas, Diane E. Stockinger, Waldy San Sebastián, Michael Macayan, Sridhar Samineni, Phillip Pivirotto, John Forsayeth et al. · 2015 · Gene Therapy
  3. Gentherapien für neuromuskuläre Erkrankungen
    Afshin Saffari, Markus Weiler, Georg Friedrich Hoffmann, Andreas Ziegler · 2019 · Der Nervenarzt
  4. Disease Modification Through Trophic Factor Delivery
    Mari H. Savolainen, Dwaine F. Emerich, Jeffrey H. Kordower · 2018 · Methods in molecular biology
  5. Engineered AAV vectors for improved central nervous system gene delivery
    Melissa A. Kotterman, David V. Schaffer · 2015 · Neurogenesis
  6. Using viral-mediated gene delivery to model Parkinson's disease: Do nonhuman primate investigations expand our understanding?
    Massimo S. Fiandaca, Howard J. Federoff · 2013 · Experimental Neurology
  7. Selective transduction of cerebellar Purkinje and granule neurons using delivery of AAV-PHP.eB and AAVrh10 vectors at axonal terminal locations
    Magdalena Surdyka, Ewelina Jesion, Anna Niewiadomska-Cimicka, Yvon Trottier, Żaneta Kalinowska-Pośka, Maciej Figiel · 2022 · Frontiers in Molecular Neuroscience
  8. In utero delivery of rAAV2/9 induces neuronal expression of the transgene in the brain: towards new models of Parkinson’s disease
    Lucie Chansel‐Debordeaux, Mathieu Bourdenx, Sandra Doveró, Virginie Grouthier, Nathalie Dutheil, Agnès Espana, Laurent Groc, Clément Jimenez, Erwan Bézard, Benjamin Dehay · 2017 · Gene Therapy
  9. Significance of gene therapy in neurodegenerative diseases
    Lingling Wang, Lin Ma, Zihan Gao, Ying Wang, Jiaoxue Qiu · 2025 · Frontiers in Neuroscience
  10. Neurotrophin mimetics and tropomyosin kinase receptors: a futuristic pharmacological tool for Parkinson’s
    Jeyaram Bharathi Jeyabalan, Nagarjuna Palathoti, Muralikrishnan Dhanasekaran, R. Sivasamy, Sivasankaran Ponnusankar, S. P. Dhanabal, Veintramuthu Sankar, Antony Justin · 2023 · Neurological Sciences
  11. Small RNA drugs for prion disease: a new frontier
    Amrit S. Boese, Anna Majer, Reuben Saba, Stephanie A. Booth · 2013 · Expert Opinion on Drug Discovery
  12. Therapeutic Plasma Exchange and Multiple Sclerosis Dysregulations: Focus on the Removal of Pathogenic Circulatory Factors and Altering Nerve Growth Factor and Sphingosine-1-Phosphate Plasma Levels
    Dimitar G. Tonev, Albena Momchilova · 2023 · Current Issues in Molecular Biology
  13. Investigational Gene Therapies for Parkinson's Disease
    Nicolás M. Phielipp, Claire Henchcliffe · 2025 · CNS Drugs
  14. Targeting Neurons of Rat Nucleus Tractus Solitarii with the Gene Transfer Vector Adeno-Associated Virus Type 2 to Up-Regulate Neuronal Nitric Oxide Synthase
    Li‐Hsien Lin, Deidre Nitschke Dragon, Jingwen Jin, William T. Talman · 2011 · Cellular and Molecular Neurobiology
  15. Engineered zinc finger repressors induce a prolonged and selective repression of SCN9A in nociceptors of nonhuman primates
    Mohammad Samie, Toufan Parman, Mihika Jalan, Jisoo Lee, Patrick Dunn, Jason A. Eshleman, Dianna Baldwin Vidales, Kenneth Kennard, Josh Holter, Brian Jones et al. · 2026 · Science Translational Medicine
  16. How Relevant Are Imaging Findings in Animal Models of Movement Disorders to Human Disease?
    Darryl Bannon, Anne Marlene Landau, Doris J. Doudet · 2015 · Current Neurology and Neuroscience Reports
  17. Bioreducible Gene Delivery Platform that Promotes Intracellular Payload Release and Widespread Brain Dispersion
    Divya Rao, Gijung Kwak, Heng Wang, Charles G. Eberhart, Justin S. Hanes, Jung Soo Suk · 2023 · ACS Biomaterials Science & Engineering
  18. Evaluation of AAV Capsids and Delivery Approaches for Hereditary Hemorrhagic Telangiectasia Gene Therapy
    Alka Yadav, Rich Liang, Kelly Press, Annika Schmidt, Zahra Shabani, Kun Leng, Calvin Wang, Abinav Sekhar, Joshua Shi, Garth W. Devlin et al. · 2024 · Translational Stroke Research
  19. Role of Genes and Treatments for Parkinson’s Disease
    Falaq Naz, Yasir Hasan Siddique · 2020 · The Open Biology Journal
  20. Gene Therapy for Parkinson’s Disease
    Michael Douglas, Jonathan Hazlehurst · 2011 · InTech eBooks
  21. Disease mechanisms as Subtypes: Mitochondrial and bioenergetic dysfunction
    Patricia González‐Rodríguez, Enrico Zampese, Dalton James Surmeier · 2023 · Handbook of clinical neurology
  22. Assessment of Hippocampal Adeno-Associated Viral Vector Gene Delivery via Frameless Stereotaxis in a Nonhuman Primate
    Cary H. Leung, Michele Ann Kliem, Brenten L. Heeke, Scott McPhee, Thais Federici, Brooke R. Snyder, Nicholas M. Boulis · 2011 · Stereotactic and Functional Neurosurgery
  23. Viral vectors in neurodegenerative diseases: immune responses and therapeutic applications
    Yifei Wang, Shuqi Mu, Fangxi Liu · 2025 · Frontiers in Neurology
  24. Updates on the Pathogenesis and Therapeutic Approaches for Hereditary Hemorrhagic Telangiectasia
    Alka Y, Zahra Shabani, Jasneet Kaur Dhaliwal, Annika Schmidt, Hua Su · 2025 · Current Vascular Pharmacology
  25. Regulatory Elements for Gene Therapy of Epilepsy
    Ekaterina Chesnokova, Natalia V. Bal, Ghofran Alhalabi, Pavel M. Balaban · 2025 · Cells
  26. GDNF and AADC Gene Therapy for Parkinson’s Disease
    Krystof S. Bankiewicz, Waldy San Sebastián, Lluı́s Samaranch, John Forsayeth · 2016 · Springer eBooks
  27. Gene Delivery and Gene Therapy for Alzheimer’s Disease
    Maya E. Woodbury, Tomomi Kiyota, Tsuneya Ikezu · 2015 · Neuromethods
  28. Systemic Gene Delivery by Single-Dose Intracardiac Administration of scAAV2/9 and scAAV2/rh10 Variants in Newborn Rats
    Lucie Chansel‐Debordeaux, Mathieu Bourdenx, Nathalie Dutheil, Sandra Doveró, Marie‐Hélène Canron, Clément Jimenez, Erwan Bézard, Benjamin Dehay · 2018 · Human Gene Therapy Methods
  29. Direct Convective Nervous System Drug Delivery for Patients with Neurodegenerative Disorders
    Robert Mark Richardson, Paul Larson · 2019 · Elsevier eBooks
  30. Advances in targeting neurotransmitter systems in dystonia
    Dora Steel, Kimberley M. Reid, Antonio Pisani, Ellen J. Hess, Susan Helen Fox, Manju A. Kurian · 2023 · International review of neurobiology
  31. Viral Vectors in Primate Research: Examples from Parkinson’s Disease Research
    Grégory Porras, Benjamin Dehay, Erwan Bézard · 2013 · Neuromethods
  32. The Use of Viral Vectors to Enhance Cognition
    Tsuneya Ikezu · 2015 · Elsevier eBooks
  33. Therapeutic Strategies in Neurodegenerative Diseases
    Abdulmunaim M. Eid, Alireza Faridar, Stanley H. Appel · 2024 · Springer eBooks
  34. Efficient transduction of adeno-associated virus vectors into gerbil hippocampus with an appropriate combination of viral capsids and promoters
    Yoshihide Sehara, Kuniko Shimazaki, Fumio Kurosaki, Naoki Kaneko, Ryosuke Uchibori, Masashi Urabe, Kensuke Kawai, Hiroaki Mizukami · 2018 · Neuroscience Letters
  35. Transduction catalysis: doxorubicin accelerates and enhances rAAV-mediated gene expression in the cortex of mouse, cat and monkey
    Hongliang Gong, Nini Yuan, Zhiming Shen, Cheng Tang, Stewart D. Shipp, Liling Qian, Yiliang Lu, Ian Max Andolina, Shenghai Zhang, Jihong Wu et al. · 2020 · bioRxiv (Cold Spring Harbor Laboratory)
  36. Author Response: Safety of AADC Gene Therapy for Moderately Advanced Parkinson Disease: Three-Year Outcomes From the PD-1101 Trial
    Chadwick W. Christine, Robert Mark Richardson, Elisabeth M. Fine, Omar Khwaja, Grace S. Lin Liang, Andreas Meier, Eiry W. Roberts, Krystof S. Bankiewicz, Paul Larson · 2022 · Neurology
  37. Cell type-selective AADC expression reduces motor deficits and dyskinesia in Parkinson’s disease mouse models
    Ananya Chowdhury, Alex Fraser, Maxwell Departee, Naz Taskin, Meagan A. Quinlan, John K. Mich, Victoria Omstead, Nathaly Lerma, Ximena Opitz-Araya, Alex C. Hughes et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)
  38. CLINICAL DEVELOPMENT OF AAV VECTORS
    Barrie J. Carter · 2010 · Gene Therapy and Regulation
  39. Gene therapies for spinocerebellar ataxia type 1
    Megan Kathryn Keiser · 2013
  40. Chemogenetics, Induced Neurons and Pluripotent Stem Cells: Towards Advanced Gene and Cell Therapies Targeting Epilepsy
    Natalia Avaliani · 2015 · Lund University Publications (Lund University)
  41. [Advances in the application of gene therapy for Parkinson's disease with adeno-associated virus].
    Yang Chen, Yinghui Lü, Zhaofa Li · 2014 · PubMed
  42. Clinical Safety and Applications of Stem Cell Gene Therapy
    Carlo Stephan Jackson, Marco Alessandrini, Michael Sean Pepper · 2017 · Stem cells in clinical applications
  43. Gene Therapy Approaches for Neurological Lysosomal Storage Diseases
    Victoria J. McCurdy · 2014
  44. RNA interference therapy for the Spinocerebellar ataxias
    Pavitra S. Ramachandran · 2014
  45. Gene delivery for Parkinson's disease
    Piotr Chmielarz, Anne E. Panhelainen, Mikko Airavaara, Andrii Domanskyi · 2020 · Elsevier eBooks
  46. Silencing Hyper-Excitable Neurons as a Treatment for Status Epilepticus and Temporal Lobe Epilepsy.
    Deblina Dey · 2013
  47. Francisco llama a anunciar con alegría el evangelio
    Martín Gelabert Ballester · 2013 · Teología Espiritual
  48. Gene Therapy for Neurological Diseases
    Massimo S. Fiandaca, Shreyas Mahapatra, Suresh de Silva, William J. Bowers, Howard J. Federoff · 2015 · CRC Press eBooks
  49. NANONEUROLOGY
    Rodica Bălașa · 2015 · Romanian Journal of Neurology
  50. Gene Therapy For Neurological Disorders: Parkinson’s Disease And Glioblastoma
    Pinshu Zhao, Tori Goertz · 2022 · Journal of Student Research
  51. Gene therapy under clinical trials for neurodegenerative diseases
    Bhupender Sahu, Lakshita Tyagi, Prshant Tyagi, Umesh Kumar · 2024 · Elsevier eBooks
  52. GDNF Gene Therapy for Parkinson’s Disease
    Adrian P. Kells, Amber D. Van Laar, Krystof S. Bankiewicz · 2025 · Springer eBooks
  53. Recent Therapies Including Gene Therapy and Immunotherapy in Overcoming the Gaps in the Treatment of Neurodegeneration
    Sakshi Goswami, Yeshvandra Verma, Suresh Vir Singh Rana · 2026 · Springer eBooks
  54. Industry Perspective on Translational and Clinical Pharmacology Aspects of Viral-based Gene Therapies and Vaccines—Key Considerations and Learnings From Approved Products
    Hardik R. Mody, Jatin Narula, Prathap Nagaraja Shastri, Dale Miles, Yun Liu, Vittal Shivva, Jimit Girish Raghav, Gillie A. Roth, Anshul Gupta, Bahru A. Habtemariam et al. · 2026 · The AAPS Journal
  55. The Mechanism of the Parkin-CMA-NLRP3-PANoptosis Signaling Axis in Parkinson's Disease: From Molecular Basis to Therapeutic Strategies
    Xinghua Tian, Biao Zhang, Yu Wang, Jianshe Wei · 2026 · Progress in Neurobiology
  56. Alpha-synuclein and neuromelanin converge to promote Parkinson’s disease pathology
    Alba Nicolau, Marta González-Sepúlveda, Joana M. Cladera-Sastre, Thais Cuadros, Annabelle Parent, Gerard Roch, Jacopo Marongiu, Benjamin Huynh, Anahid Ansari Mahabadian, Feifei Su et al. · 2026 · bioRxiv (Cold Spring Harbor Laboratory)